Professor of Medicine, Cleveland Cl College of Medicine/Case West Res
Hematology
Dr. David J. Adelstein, MD
|
|
Give Review
David J. Adelstein, MD practices Hematology. He researched medicine at NYU School of Medicine. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Top MD". David Adelstein is a published MD. He has 60 publications published. The most current publication "Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With Chemoradiotherapy." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Current Status of Clinical Trials in Head and Neck Cancer 2014.
- Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
- In squamous cell head and neck Cancer: which platinum, how much and how often?
- A randomized phase III study of two cisplatin based chemoradiation (CCRT) regimens in locally advanced head and neck squamous Cell carcinoma (LAHNSCC): The impact of c...
- Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective Analysis of two clinical trials.
- Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous Cell carcinoma of the oropharynx.
- Induction chemotherapy meta-Analysis in head and neck cancer: right answer, wrong question.
- A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal Cancer.
- Salvage Laryngectomy in Patients with Recurrent Laryngeal Cancer in the Setting of Nonoperative Treatment Failure.
- Transoral resection of pharyngeal Cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7...
- Enteral Feeding Tubes in Patients Undergoing Definitive Chemoradiation Therapy for Head-and-Neck Cancer: A Critical Review.
- Biology and management of salivary gland Cancers.
- Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenoCarcinoma of the esophagus and gastroesophage...
- Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous Cell carcinoma of the head and neck.
- Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell Cancer in the elderly.
- Role of positron emission tomography in management of sinonasal neoplasms-a single institution's experience.
- A phase II trial of gefitinib for recurrent or metastatic Cancer of the esophagus or gastroesophageal junction.
- Intended single-modality management of T1 and T2 tonsillar Carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution.
- What is new in the management of salivary gland Cancers?
- Severe local toxicity after Lung stereotactic body radiation therapy: lesional abscess leading to bronchocutaneous fistula requiring surgical marsupialization.
- Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy.
- Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous Cell carcinoma.
- Human papillomavirus: changing paradigms in oropharyngeal Cancer.
- Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients wi...
- A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esop...
- Survival trends in head and neck Cancer: opportunities for improving outcomes.
- Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning Analy...
- Head and neck squamous cell Cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, ...
- Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis Cancer of the esophagus and gastroesophageal junction.
- Does vocal cord fixation preclude nonsurgical management of laryngeal Cancer?
- Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.
- Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for Cancer.
- Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
- Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung Cancer: insights for radiotherapy planning...
- Redefining the role of induction chemotherapy in head and neck Cancer.
- Current and emerging standards of concomitant chemoradiotherapy.
- Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal Cancer.
- Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous Cell carcinoma after definitive chemoradiotherapy.
- A phase II trial of accelerated multimodality therapy for locoregionally advanced Cancer of the esophagus and gastroesophageal junction: the impact of clinical heterog...
- T2N0M0 esophageal Cancer.
- Validation of the RTOG recursive partitioning Analysis (RPA) classification for small-cell lung cancer-only brain metastases.
- Concurrent chemoradiotherapy in the management of squamous cell Cancer of the oropharynx: current standards and future directions.
- Risk factors for hypopharyngeal/upper Esophageal stricture formation after concurrent chemoradiation.
- Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck Cancer?
- Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck Cancer: mature results from a single institution.
- Induction redux: once more with taxanes.
- Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal Cancer.
- Endoscopic ultrasound errors in esophageal Cancer.
- Organ preservation for advanced resectable Cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
- Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal Carcinoma.
- Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck Cancer?
- Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung Cancer.
- Factors associated with improved survival in patients with brain metastases from esophageal Cancer: a retrospective review.
- Role of clinically determined depth of tumor invasion in the treatment of esophageal Carcinoma.
- Refining esophageal Cancer staging.
- Oropharyngeal Cancer: the role of chemotherapy.
- An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous Cell head and...
- Stage III non-small cell lung Cancer and metachronous brain metastases.
- Maximizing local control and organ preservation in stage IV squamous cell head and neck Cancer With hyperfractionated radiation and concurrent chemotherapy.
Schools
New York University School Of Medicine
University Hosps Cleveland
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Case Western Reserve University - University Hospitals -
NYU School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1922061365 | |
| NPPES Provider LastName | ADELSTEIN | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 331.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 31.0 | |
| Percent Opioid Claims | 9.37 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922061365 |
| Last Name Of The Provider | ADELSTEIN |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Glen H. Stevens, DO |
|
Dr. Stanton L. Gerson, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Alvin H. Schmaier, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Murali Janakiram, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph Gibbons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cortney V. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rose C. Beck, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lalitha V. Nayak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron T. Gerds, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rania Rayes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nathan Levitan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Vollweiler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul F. Hergenroeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinita Gupta, MD |
|
|
Dr. Archana C. Rao, MD |